Repare Therapeutics Inc
RPTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$114.24M
Close$
Share Statistics
| Market cap | $114.24 Million |
|---|---|
| Enterprise Value | $41.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2 |
| Beta | 0.96 |
| Outstanding Shares | 42,965,529 |
Return
| Return on Equity | -62.71% |
|---|---|
| Return on Assets | -56.96% |
| Return on Invested Capital | -66.34% |
Valuation & Multiples
| P/E Ratio | -1.58 |
|---|---|
| PEG | 1.44 |
| Price to Sales | -2.65 |
| Price to Book Ratio | 1.33 |
| Enterprise Value to Revenue | -1 |
| Enterprise Value to EBIT | -0.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 2, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$2.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7875▲ 78.75% |
|---|---|
| Total Calls | 251,300▲ 132.47% |
| Total Puts | 197,900▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 58.56%▼ 4.98% |
|---|---|
| Total Invested | $65.42M▲ 36.31% |
| Investors Holding | 52▲ 7.00% |
ESG Score
No data